Life style Modification | OGLDs Treatment | Insulin Therapy | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Question | Pre-test | Post-test | Diff (%) | P-value | Pre-test | Post-test | Diff (%) | P-value | Pre-test | Post-test | Diff (%) | P-value |
Q10: Lifestyle modification recommendation | 90.8 | 93.1 | 2.3 | 0.1 | Â | Â | Â | Â | Â | Â | Â | Â |
Q11: Advice on healthy diet | 46.6 | 74.3 | 27.7 | 0.000 | Â | Â | Â | Â | Â | Â | Â | Â |
Q12: Physical activity advice | 60.0 | 78.7 | 18.7 | 0.000 | Â | Â | Â | Â | Â | Â | Â | Â |
Q13: Medical treatment+ life style change | Â | Â | Â | Â | 66.1 | 82.1 | 15.9 | 0.000 | Â | Â | Â | Â |
Q14: Concurrent medical therapy | Â | Â | Â | Â | 68.8 | 68.8 | 0 | 1.000 | Â | Â | Â | Â |
Q15: Combination therapy | Â | Â | Â | Â | 46.7 | 71.1 | 24.3 | 0.000 | Â | Â | Â | Â |
Q16: HbA1c level to recommend combination therapy | Â | Â | Â | Â | 54.1 | 85.7 | 31.6 | 0.000 | Â | Â | Â | Â |
Q17: First choice OGLD | Â | Â | Â | Â | 71.8 | 88.4 | 16.6 | 0.000 | Â | Â | Â | Â |
Q18: Metformin dose at initiation | Â | Â | Â | Â | 59.6 | 63.8 | 4.2 | 0.0518 | Â | Â | Â | Â |
Q19: Optimal dose of sulfonylurea | Â | Â | Â | Â | 62.7 | 89.1 | 24.4 | 0.000 | Â | Â | Â | Â |
Q23: Metformin dose titration | Â | Â | Â | Â | 45.2 | 50.9 | 5.7 | 0.005 | Â | Â | Â | Â |
Q24: Adding basal insulin | Â | Â | Â | Â | Â | Â | Â | Â | 61.7 | 86.5 | 24.8 | 0.000 |
Q25: Insulin regimen | Â | Â | Â | Â | Â | Â | Â | Â | 19.9 | 54.3 | 34.4 | 0.000 |
Q26: Basal insulin dose titration based on FBS | Â | Â | Â | Â | Â | Â | Â | Â | 22.2 | 38.3 | 16.1 | 0.000 |
Q27: Indication for up-titration of basal insulin | Â | Â | Â | Â | Â | Â | Â | Â | 58.5 | 68.4 | 9.9 | 0.000 |
Q28:Indication for adding prandial insulin | Â | Â | Â | Â | Â | Â | Â | Â | 63.5 | 76.5 | 13 | 0.000 |